Therapeutic Approaches for Inflammatory Bowel Disease: The Role of Immunomodulators, Biologics, and 5-Aminosalicylates in Cardiovascular Risk Management - Top-Institutions - MDSpire

Therapeutic Approaches for Inflammatory Bowel Disease: The Role of Immunomodulators, Biologics, and 5-Aminosalicylates in Cardiovascular Risk Management

  • By

  • Qi Jian

  • Naueen A. Chaudhry

  • Fanxing Du

  • Ellen Zimmermann

  • Tianze Jiao

  • April 29, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Gastroenterology
    • Cardiology
    • Immunology

  • #2

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Gastroenterology
    • Cardiology
    • Inflammation Research

  • #3

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Gastroenterology
    • Cardiology
    • Immunology

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Gastroenterology
    • Cardiology
    • Translational Medicine

  • #5

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Gastroenterology
    • Cardiology
    • Clinical Research

Original Source(s)

Therapeutic Approaches for Inflammatory Bowel Disease: The Role of Immunomodulators, Biologics, and 5-Aminosalicylates in Cardiovascular Risk Management

  • by Qi Jian, Naueen A. Chaudhry, Fanxing Du, Ellen Zimmermann, Tianze Jiao

  • April 29, 2026

Related Content

Occludin takes centre stage in HIV defence and stroke

REACHing forward—a strategic vision for ECCO and the future of IBD care

AI-driven low-cost rehabilitation exergame as a lightweight framework for stroke assessment